- Home
- VIVK vs CELU Comparison
VIVK vs CELU Comparison
Compare VIVK & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVK
- CELU
- Stock Information
- Founded
- VIVK 2006
- CELU 2016
- Country
- VIVK United States
- CELU United States
- Employees
- VIVK N/A
- CELU N/A
- Industry
- VIVK Oilfield Services/Equipment
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- VIVK Energy
- CELU Health Care
- Exchange
- VIVK Nasdaq
- CELU Nasdaq
- Market Cap
- VIVK 38.4M
- CELU 42.2M
- IPO Year
- VIVK N/A
- CELU N/A
- Fundamental
- Price
- VIVK $0.83
- CELU $3.48
- Analyst Decision
- VIVK
- CELU
- Analyst Count
- VIVK 0
- CELU 0
- Target Price
- VIVK N/A
- CELU N/A
- AVG Volume (30 Days)
- VIVK 348.9K
- CELU 143.3K
- Earning Date
- VIVK 08-26-2025
- CELU 05-08-2025
- Dividend Yield
- VIVK N/A
- CELU N/A
- EPS Growth
- VIVK N/A
- CELU N/A
- EPS
- VIVK N/A
- CELU N/A
- Revenue
- VIVK $111,130,140.00
- CELU $54,220,000.00
- Revenue This Year
- VIVK N/A
- CELU $23.29
- Revenue Next Year
- VIVK N/A
- CELU N/A
- P/E Ratio
- VIVK N/A
- CELU N/A
- Revenue Growth
- VIVK 85.84
- CELU 138.11
- 52 Week Low
- VIVK $0.55
- CELU $1.00
- 52 Week High
- VIVK $2.05
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- VIVK 43.37
- CELU 61.75
- Support Level
- VIVK $0.81
- CELU $3.03
- Resistance Level
- VIVK $1.07
- CELU $3.64
- Average True Range (ATR)
- VIVK 0.14
- CELU 0.24
- MACD
- VIVK -0.02
- CELU -0.02
- Stochastic Oscillator
- VIVK 3.82
- CELU 75.25
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.